Skip to main content

Advent International to Acquire PatientPoint, the Point of Change Company, Elevating Healthcare Through the Nation’s Largest Digital Point-Of-Care Engagement Network

Advent International (“Advent”), a leading global private equity investor, today announced that it has signed a definitive agreement to acquire PatientPoint, Inc. (“PatientPoint” or the “Company”), the nation’s largest digital point-of-care network, strategically delivering behavior-changing content and measurable outcomes for patients, providers, and health brands, from an investor group led by L Catterton and Littlejohn & Co., LLC (“Littlejohn”). Terms of the transaction were not disclosed.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250825846474/en/

PatientPoint has more than 35 years of experience transforming the point-of-care experience by delivering actionable, educational content, and diagnostic tools to patients and healthcare providers. Through an interconnected nationwide network of 30,000 physician offices and 125,000 providers, PatientPoint delivers measurable outcomes while connecting patients, providers, and health brands with relevant information at critical moments of care. PatientPoint’s platform improves health awareness and drives positive behavior changes while enabling pharmaceutical and health brand sponsors, health associations, advocacy groups, and other organizations to reach highly targeted audiences.

Chris Comenos, Director at Advent, said, “We are thrilled to partner with PatientPoint, a leader in digital point-of-care engagement, as it continues its mission of helping patients take a more active role in understanding and managing their healthcare. We're excited to help the Company provide increasingly targeted messaging about treatment options and advanced therapies, offering sponsors and partners more efficient, personalized, and measurable campaigns. Given the platform's position in a patient’s healthcare journey, we also believe it has strong potential to deliver new, innovative solutions that will drive beneficial health outcomes over time.”

Carmine Petrone, Managing Director at Advent, added, “Drawing on Advent’s deep experience scaling innovative healthcare and pharmaceutical services companies, we look forward to working closely with CEO Sean Slovenski and the PatientPoint team to accelerate the Company’s network expansion and drive product innovation through this large and growing channel – delivering even greater value to providers, partners, and patients nationwide.”

Sean Slovenski, CEO of PatientPoint, said, “From the beginning, PatientPoint has been committed to a clear mission: driving better health outcomes by delivering trusted, behavior-changing education in the doctor’s office, where decisions are made. With Advent, we can accelerate growth, expand our network, and continue to deliver measurable value for providers, patients, and health brands.

“At PatientPoint, our clients and healthcare providers are at the heart of everything we do,” said Linda Ruschau, Chief Commercial Officer of PatientPoint. “This new partnership is an incredible catalyst for growth. Advent gives us the resources to innovate faster, expand our reach, and deliver even more value to our clients as they look to engage audiences at the point of care and beyond.”

“Our partnership with PatientPoint has been defined by a shared belief in its mission to transform the point-of-care experience for patients, providers, and healthcare sponsors,” said Andrew Taub, a Managing Partner at L Catterton. “We are proud to have leveraged our deep understanding of consumers to support the Company’s growth into becoming the clear market leader in patient engagement and grateful to the team for their vision and dedication.”

“PatientPoint’s growth over the past several years has been remarkable, and we have been privileged to support the Company through this important phase of its evolution,” said Drew Greenwood, Managing Director at Littlejohn. “We look forward to seeing the Company continue to expand its impact and leadership in the years ahead.”

PatientPoint will continue to be led by its existing management team, with support from Advent’s deep bench of advisors with relevant healthcare and digital expertise.

The acquisition underscores Advent’s conviction in the rapidly growing point-of-care market, which is benefiting from strong industry tailwinds as promotional spend shifts toward more digital and measurable channels. This investment builds upon Advent’s growing portfolio of healthcare and technology companies, including investments in Simtra BioPharma Solutions, Iodine (Waystar), Cohance Lifesciences (formed following the merger of Suven Pharmaceuticals), Mediq, GS Capsule, and Apollo HealthCo.

The transaction is expected to close in the fourth quarter of 2025, subject to customary regulatory approvals and closing conditions.

Jefferies and Citi served as financial advisors and Gibson Dunn & Crutcher LLP served as legal advisor to PatientPoint. Solomon Partners served as financial advisor and Ropes & Gray LLP served as legal advisor to Advent.

About Advent International

Advent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. With 16 offices across five continents, we oversee more than USD $94 billion in assets under management* and have made 430 investments across 44 countries.

Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology. This approach is bolstered by our deep sub-sector knowledge, which informs every aspect of our investment strategy, from sourcing opportunities to working in partnership with management to execute value creation plans. We bring hands-on operational expertise to enhance and accelerate businesses.

As one of the largest privately-owned partnerships, our 660+ colleagues leverage the full ecosystem of Advent’s global resources, including our Portfolio Support Group, insights provided by industry expert Operating Partners and Operations Advisors, as well as bespoke tools to support and guide our portfolio companies as they seek to achieve their strategic goals.

To learn more, visit our website or connect with us on LinkedIn.

*Assets under management (AUM) as of March 31, 2025. AUM includes assets attributable to Advent advisory clients as well as employee and third-party co-investment vehicles.

About PatientPoint

PatientPoint® is the Point of Change company, transforming the healthcare experience through the strategic delivery of behavior-changing content at critical moments of care. As the nation’s largest and most impactful digital network in 30,000 physician offices, we connect patients, providers and health brands with relevant information that is proven to drive healthier decisions and better outcomes. Learn more at patientpoint.com.

About L Catterton

L Catterton is a market-leading consumer-focused investment firm, managing approximately $37 billion of equity capital across three multi-product platforms: private equity, credit, and real estate. The firm's funds have the ability to invest between $5 million and $5 billion, across the capital structure, in well-positioned consumer businesses. Leveraging deep category insight, operational excellence, and a broad network of strategic relationships, L Catterton's team of more than 200 investment and operating professionals across 18 offices partners with management teams to drive differentiated value creation across its portfolio. Founded in 1989, the firm has made over 300 investments in some of the world's most iconic consumer brands. For more information about L Catterton, please visit www.lcatterton.com.

About Littlejohn & Co.

Littlejohn & Co. is a Greenwich, Connecticut-based investment firm focused on private equity and debt investments in growing middle-market industrial and services companies that can benefit from Littlejohn’s 25+ years of operational and sector expertise. With approximately $8 billion in regulatory assets under management, the firm seeks to build sustainable success for its portfolio companies through a disciplined approach to engineering change. For more information about Littlejohn, visit www.littlejohnllc.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.